Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Gastroesophageal Junction Adenocarcinoma
Regimen:
TCF (5-fluorouracil + carboplatin + docetaxel)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
12/23/2020
Excerpt:
Gastroesophageal Junction Adenocarcinoma: Principles of systemic therapy…Other recommended regimens…Docetaxel, carboplatin, and fluorouracil
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login